Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
2011 · Clinical Cancer Research · 256 citations
https://doi.org/10.1158/1078-0432.ccr-11-0071
F
Fengyan Yu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
82
Papers
5.1K
Citations
24
h-index
28
i10-index
Fengyan Yu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: MicroRNA in disease regulation & RNA Interference and Gene Delivery & Cancer-related molecular mechanisms research. The author has an h-index of 24, co-authored 70 publications.
ORCID: 0000-0002-9996-4576Papers by this author
worksTargeted Delivery of PLK1-siRNA by ScFv Suppresses Her2 <sup>+</sup> Breast Cancer Growth and Metastasis
2012 · Science Translational Medicine · 183 citations
https://doi.org/10.1126/scitranslmed.3003601
The Overexpression of Hypomethylated miR-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2)
2013 · Journal of Biological Chemistry · 116 citations
https://doi.org/10.1074/jbc.m112.434340
Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro
2011 · British Journal of Cancer · 89 citations
https://doi.org/10.1038/bjc.2011.190
Stable RNA interference of ErbB-2 gene synergistic with epirubicin suppresses breast cancer growth in vitro and in vivo
2006 · Biochemical and Biophysical Research Communications · 18 citations
https://doi.org/10.1016/j.bbrc.2006.05.206
Does establishing a preoperative nomogram including ultrasonographic findings help predict the likelihood of malignancy in patients with microcalcifications?
2019 · Cancer Imaging · 9 citations
https://doi.org/10.1186/s40644-019-0229-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat